PFIZER has announced the sale of its Hospira Infusion Systems unit to ICU Medical.
The US$1 billion deal includes a stock swap which will see Pfizer own almost 17% in ICU which becomes an "integrated pure-play infusion therapy company".
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Oct 16